0 results for 'BristolMyers Squibb'
2nd Circuit Upholds Dismissal of Securities Suit Targeting Bristol-Myers Squibb Over Failed Trial
The panel upheld a lower court's dismissal of a proposed securities class action, which claimed that Bristol-Myers Squibb made material misstatements or omissions around a clinical trial to determine the drug's efficacy for treating certain kinds of lung cancers.TRENDING STORIES
More from ALM
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read
- Legal Speak at Legalweek 2024: Relativity's Director of AI Transformation and Law Firm Strategy Cristin Traylor; Zeem Solutions GC and Chief Privacy Officer John Meyer 1 minute read
- Legal Speak at Legalweek 2024: Cimplifi GC Marla Crawford and Everlaw VP of Marketing Joshua Schnoll 1 minute read
Resources
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now